The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 01, 2018
Filed:
Dec. 14, 2015
Applicant:
Senhwa Biosciences, Inc., New Taipei, TW;
Inventors:
David M. Ryckman, San Diego, CA (US);
Iching Grace Yu, San Diego, CA (US);
Hshiou-ting Liu, Milpitas, CA (US);
Assignee:
SENHWA BIOSCIENCES, INC., New Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 513/14 (2006.01); A61K 31/551 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C07D 513/14 (2013.01); A61K 31/551 (2013.01); A61K 45/06 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present invention includes crystalline forms of 2-(4-Methyl-[1,4]diazepan-1-yl)-5-oxo-5H-7-thia-1,11b-diaza-benzo[c]fluorene-6-carboxylic acid (5-methyl-pyrazin-2-ylmethyl)-amide and crystalline forms of salts and/or solvates of 2-(4-Methyl-[1,4]diazepan-1-yl)-5-oxo-5H-7-thia-1,11b-diaza-benzo[c]fluorene-6-carboxylic acid (5-methyl-pyrazin-2-ylmethyl)-amide. Furthermore, the present invention provides compositions comprising the crystalline forms and therapeutic use of the crystalline forms and the compositions thereof.